Search Filters

Search Results

Found 5 results

510(k) Data Aggregation

    K Number
    K242547
    Manufacturer
    Date Cleared
    2025-05-19

    (265 days)

    Product Code
    Regulation Number
    868.5905
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    AirFit F20 Mask System:

    The AirFit F20 mask has two product variants:

    • AirFit F20 mask is intended for single-patent reuse in the home environment.
    • AirFit F20 SLM (Sleep Lab Mask) variant is intended for multi-patient reuse in the hospital/institutional environment.

    Both masks are intended for patients weighing more than 66lb (30kg), who have been prescribed non-invasive CPAP or bi-level positive airway pressure (PAP) therapy. The Sleep Lab Mask is the only variant that is validated and intended for multi-patient reprocessing and must be reprocesssed if reused between patients.

    AirFit F20 NM Mask System:

    The AirFit F20 Non Magnetic mask has two product variants:

    • The AirFit F20 Non Magnetic variant is intended for single-patient reuse in the home environment.
    • The AirFit F20 Non Magnetic SLM (Sleep Lab Mask) variant is intended for multi-patient reuse in the hospital/institutional environment.

    This mask is for patients weighing more than 66 lb (30 kg), who have been prescribed non-invasive CPAP or bi-level positive airway pressure (PAP) therapy. The Sleep Lab Mask is the only variant that is validated and intended for multi-patient reprocessing and must be reprocessed if reused between patients.

    Device Description

    The AirFit F20 and AirFit F20 NM Mask Systems are both full-face masks intended for use with Continuous Positive Airway Pressure (CPAP) and/or Bi-Level devices. CPAP & Bi-Level devices are used for the treatment of Obstructive Sleep Apnea (OSA) and/or ventilatory support. Both treatments deliver pressurized air from a flow generator to the patient. Such delivery of pressurized air relies on the Patient Interface; commonly known as the mask. Full face masks are a common type of Patient Interface (Mask) and are known to efficaciously support the delivery of pressurized air by providing a seal around the patient's nose and mouth.

    The AirFit F20 mask system has two product variants:

    • AirFit F20 Mask: This is the home use variant that is intended for single patient re-use.
    • AirFit F20 SLM (sleep lab mask): This is the variant that is intended for multi-patient re-use and must be reprocessed if reused between patients using the disinfection guide.

    AirFit F20 (K170924) had a "For Her" variant which was cleared with aesthetic colour pops, the AirFit F20 Mask and AirFit F20 SLM also have the same "For Her" variant.

    The AirFit F20 NM mask system has two product variants:

    • AirFit F20 NM Mask: This is the home use variant that is intended for single patient re-use.
    • AirFit F20 NM SLM (sleep lab mask): This is the variant that is intended for multi-patient re-use and must be reprocessed if reused between patients using the disinfection guide.

    The AirFit F20 and AirFit F20 NM Mask Systems share a common design architecture as the predicate AirFit F20 (K170924), except that the AirFit F20 NM Mask System has non-magnetic clips.

    The AirFit F20 and AirFit F20 NM mask systems are made up of the following four main component assemblies: cushion, elbow, frame, and headgear. The cushion and headgear are available in various sizes to allow for adequate mask fit over the intended patient population.

    The AirFit F20 and AirFit F20 NM mask systems are prescription devices supplied non-sterile.

    AI/ML Overview

    The provided FDA 510(k) clearance letter and associated summary pertain to the AirFit F20 Mask Systems, which are non-continuous ventilators (CPAP/Bi-Level masks). This type of device does not typically involve complex diagnostic algorithms or AI components that would necessitate the study structure outlined in your request (e.g., test sets, ground truth, expert adjudication, MRMC studies, standalone performance for AI).

    Instead, the clearance is based on demonstrating substantial equivalence to a predicate device (AirFit F20, K170924) through non-clinical performance and safety testing, adherence to recognized standards, and biocompatibility evaluations.

    Therefore, many of the specific questions you've asked cannot be directly answered from this document as they are not relevant to the type of device and clearance process involved.

    Here's an attempt to extract the relevant information and address your questions where possible:


    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly present a "table of acceptance criteria" with corresponding "reported device performance" in a format typically used for diagnostic algorithm validation. Instead, it compares specific design parameters and performance characteristics of the new devices (AirFit F20 Mask System and AirFit F20 NM Mask System) against the predicate device (AirFit F20, K170924). The "Comments" column often indicates that the performance is "Equivalent" or "Identical," implying that the new devices meet or perform similarly to the established safety and performance profile of the predicate, which serves as the de facto acceptance benchmark.

    Here's a summary derived from the comparison table (Pages 9-12 of the provided document):

    Design parameter or featurePredicate device: AirFit F20, K170924 (Performance/Criteria based on predicate)Modified device: AirFit F20 Mask System (Reported Performance)Modified device: AirFit F20 NM Mask System (Reported Performance)Acceptance Criteria (Implied)
    Indications for UseSpecified for CPAP/bi-level, >66lb (30kg), single-patient home, multi-patient hospital use.Equivalent to predicate, with variants for home/sleep lab use.Equivalent to predicate, with variants for home/sleep lab use.Equivalent to predicate
    Intended UseInterface for CPAP/bi-level devices.IdenticalIdenticalIdentical to predicate
    FDA Product CodeBZDBZDBZDIdentical to predicate
    Patient populationWeighing more than 66 lb (30 kg)Patients weighing more than 66lb (30kg)Patients weighing more than 66lb (30kg)Identical to predicate
    Environment of UseHome or health institutionHome or health institutionHome or health institutionIdentical to predicate
    Reprocessing claimsSingle patient re-use or multi-patient re-use.IdenticalIdenticalIdentical to predicate
    Sterility state as providedNon-sterileNon-sterileNon-sterileIdentical to predicate
    Validated reprocessing methodsHigh-Level Thermal disinfection, SterilizationHigh-Level Thermal disinfection, SterilizationHigh-Level Thermal disinfection, SterilizationIdentical to predicate
    Vent typeMulti-hole ventMulti-hole vent and diffuser ventMulti-hole vent and diffuser ventEquivalent to predicate's safety/efficacy profile
    PAP tubing connection pointISO 5356-1 (22mm)ISO 5356-1 (22mm)ISO 5356-1 (22mm)Identical to predicate
    Construction materialPolymeric, Textile, magnetsPolymeric, Textile, magnetsPolymeric, TextileEquivalent to predicate's safety/efficacy profile (NM variant removes magnets)
    Operating pressure range (cmH2O)3 - 403 – 403 – 40Identical to predicate
    SizesCushion (3), Headgear (3), Frame (1)IdenticalIdenticalIdentical to predicate
    Mask exhaust flow (Nominal) ISO 17510:2015 Annex BPressure (cm H2O): 3, 20, 40 -> Flow (L/min) 'Full Face' curve: 20.1, 55.5, 82.4Pressure (cm H2O): 3, 20, 40 -> Flow (L/min) 'Full Face' curve: 19, 54, 82Pressure (cm H2O): 3, 20, 40 -> Flow (L/min) 'Full Face' curve: 19, 54, 82Equivalent to predicate (minor differences within acceptable range for substantial equivalence)
    CO2 rebreathing performance (normal condition) ISO 17510:2015 Annex FPressure (cm H2O): 3, 5, 10 -> Relative CO2 increase Non-SLM: 14.8%, 7.5%, 6.8% SLM: 11.7%, 7.3%, 2.9%Pressure (cm H2O): 3, 5, 10 -> Relative CO2 increase Non-SLM: ≤ 11.4%, ≤ 11.4%, - SLM: 11.7%, 7.3%, 2.9%Pressure (cm H2O): 3, 5, 10 -> Relative CO2 increase Non-SLM: ≤ 11.4%, ≤ 11.4%, - SLM: 11.7%, 7.3%, 2.9%Equivalent (<20%) (as per ISO standard for substantial equivalence)
    CO2 rebreathing performance (single fault condition) ISO 17510:2015 Annex FFault (ISO 17510:2015) -> Relative CO2 increase Non-SLM: 32.3%, 39.5% SLM: 40.5%, 52.7%Fault (ISO 17510:2015) -> Relative CO2 increase Non-SLM: ≤ 53.1%, ≤ 53.1% SLM: 40.5%, 52.7%Fault (ISO 17510:2015) -> Relative CO2 increase Non-SLM: ≤ 53.1%, ≤ 53.1% SLM: 40.5%, 52.7%Equivalent (<60%) (as per ISO standard for substantial equivalence)
    Resistance to flow (Pressure drop across mask in cmH2O) ISO 17510:2015 Annex C@50 L/min: <0.8 cmH2O @100 L/min: <1.6 cmH2O@50 L/min: <0.8 cmH2O @100 L/min: <1.6 cmH2O@50 L/min: <0.8 cmH2O @100 L/min: <1.6 cmH2OEquivalent (Identical performance)
    Breathing Resistance (cmH2O) ISO 17510:2015 Annex EInspiratory: 0.44 @ 50L/min Expiratory: 0.60 @ 50L/minInspiratory: 0.6 @ 50L/min Expiratory: 0.80 @ 50L/minInspiratory: 0.6 @ 50L/min Expiratory: 0.80 @ 50L/minEquivalent (within acceptable limits for substantial equivalence)
    AAV Operating Pressures ISO 17510:2015 Annex DDe-activation: 1.5 cm H2O Activation: 1.0 cm H2ODe-activation: 2.0 cm H2O Activation: 1.5 cm H2ODe-activation: 2.0 cm H2O Activation: 1.5 cm H2OEquivalent (within acceptable limits for substantial equivalence)
    Flow generator setting on compatible ResMed CPAP and Bi-level flow generators"Full face""Full face""Full face"Identical to predicate
    SoundSound power level: 30 dBA Sound pressure level: 23 dBAMulti-hole vent: 30 dBA power, 22 dBA pressure. Diffuser vent: 21 dBA power, 13 dBA pressure.Multi-hole vent: 30 dBA power, 22 dBA pressure. Diffuser vent: 21 dBA power, 13 dBA pressure.Equivalent to predicate (Diffuser vent improves sound)
    Operating and storage temperatureOperating: 5°C to 40°C Storage: -20°C to +60°CIdenticalIdenticalIdentical to predicate
    Magnetic ClipsNumber: 4, Surface Strength: <400 mT, 50mm distance: <0.5 mTNumber: 4, Surface Strength: <400 mT, 50mm distance: <0.5 mTNumber: 0, Surface Strength: N/A, 50mm distance: N/AEquivalent (NM variant removes magnets for specific patient needs)

    2. Sample size used for the test set and the data provenance

    The document states that "Non-clinical verification and validation testing completed for the AirFit F20 and AirFit F20 NM Mask Systems demonstrated that the mask systems met all intended performance requirements." This primarily refers to bench testing and in-vitro studies.

    • Sample Size: Not explicitly stated as a number of "cases" or "patients" in the context of diagnostic performance. For physical device performance, testing involves multiple units of the product to ensure consistency and reliability, but specific sample sizes for tests (e.g., number of masks tested for exhaust flow, CO2 rebreathing, resistance) are not detailed in this summary.
    • Data Provenance: This is not a clinical study in the typical sense. The data comes from non-clinical bench testing conducted by the manufacturer (ResMed Pty Ltd, Australia, with a US office). It is not retrospective or prospective patient data from a particular country, but rather laboratory test results.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This question is not applicable. The device is a medical mask system, not a diagnostic algorithm that requires expert interpretation for a "ground truth." The "ground truth" for performance is established by recognized international standards (e.g., ISO 17510:2015 for mask performance, ISO 10993 for biocompatibility) and engineering specifications. Compliance is measured against these standards, not expert consensus on medical images or diagnoses.

    4. Adjudication method for the test set

    This question is not applicable for the same reasons as #3. Performance is determined by objective measurements against established standards.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This question is not applicable. This clearance is for a physical medical device (CPAP/Bi-Level mask), not an AI-powered diagnostic tool. There are no "human readers" or "AI assistance" in the context described for this device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This question is not applicable. This is not an algorithm or AI device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" for this device's performance is based on:

    • Compliance with international standards: For physical performance (e.g., CO2 rebreathing, exhaust flow, resistance, AAV pressures, sound) as defined by ISO 17510:2015 and other relevant ISO standards.
    • Biocompatibility testing: According to ISO 10993 series and ISO 18562 series.
    • Mechanical integrity testing: To ensure durability after various environmental stressors (home cleaning, transport, storage, operation, free fall, reprocessing).
    • Cleaning and reprocessing validation: Against standards like ISO 17664-1, ISO 17664-2, ST98, and AAMI TIR12.

    Essentially, the ground truth is objective measurement against established engineering and safety standards.

    8. The sample size for the training set

    This question is not applicable. There is no "training set" as this is not a machine learning or AI algorithm.

    9. How the ground truth for the training set was established

    This question is not applicable for the same reasons as #8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K234134
    Date Cleared
    2024-09-24

    (270 days)

    Product Code
    Regulation Number
    868.5905
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    AirFit F30i Mask System
    The AirFit F30i mask has two product variants:
    · AirFit F30i mask is intended for single-patent reuse in the home environment.
    • AirFit F30i SLM (Sleep Lab Mask) variant is intended for multi-patient reuse in the hospital/institutional environment. Both masks are intended for patients weighing more than 66lb (30kg), who have been prescribed non-invasive CPAP or bi-level positive airway pressure (PAP) therapy. The Sleep Lab Mask is the only variant that is validated and intended for multi-patient reprocessing and must be reprocesssed if reused between patients.

    AirFit F30i NM Mask System
    The AirFit F30i Non Magnetic mask has two product variants:
    · The AirFit F30i Non Magnetic variant is intended for single-patient reuse in the home environment.
    · The AirFit F30i Non Magnetic SLM (Sleep Lab Mask) variant is intended for multi-patient reuse in the hospital/institutional environment.
    This mask is for patients weighing more than 66 lb (30 kg), who have been prescribed non-invasive CPAP or bi-level positive airway pressure (PAP) therapy. The Sleep Lab Mask is the only variant that is validated and intended for multipatient reprocessing and must be reprocessed if reused between patients.

    Arcadia Mask System
    The Arcadia has two product variants:
    · Arcadia mask is intended for single-patient reuse in the home environment.
    · Arcadia SLM (Sleep Lab Mask) variant is intended for multi-patient reuse in the hospital/institutional environment.
    These masks are intended for patients weighing more than 66 lb (30kg), who have been prescribed non-invasive CPAP or bi-level positive airway pressure (PAP) therapy. The Sleep Lab Mask is the only variant that is validated and intended for multi-patient reprocessing and must be reprocesssed if reused between patients.

    Device Description

    The AirFit F30i, AirFit F30i NM and Arcadia mask systems are full-face conduit masks intended for use with Continuous Positive Airway Pressure (CPAP) and/or Bi-Level devices are used for the treatment of Obstructive Sleep Apnea (OSA) and/or non-life supporting ventilatory support. Both treatments deliver pressurized air from a flow generator to the patient. Such delivery of pressurized air relies on the Patient Interface; commonly known as the mask. Full face masks are a common type of Patient Interface (Mask) and are known to efficaciously support the delivery of pressurized air by providing a seal around the patient's nose and mouth.
    The AirFit F30i, AirFit F30i NM and Arcadia mask systems each have two product variants:

    • . AirFit F30i Mask/ AirFit F30i NM Mask/ Arcadia Mask: This is the home use variant that is intended for single patient re-use.
    • . AirFit F30i SLM/ AirFit F30i NM SLM/ Arcadia SLM (sleep lab mask): This is intended for multipatient re-use and must be reprocessed if reused between patients using the disinfection guide
      The AirFit F30i, AirFit F30i NM and Arcadia mask systems are made up of the following four main component assemblies: Cushion, conduit frame, elbow and headgear. The cushion and conduit frame are available in various sizes to allow for adequate mask fit over the intended patient population.
      The AirFit F30i, AirFit F30i NM and Arcadia mask systems are prescription devices supplied non-sterile.
    AI/ML Overview

    The provided text does not contain detailed information about the acceptance criteria or a specific study that proves the device meets those criteria in the format requested. The document is a 510(k) summary and FDA clearance letter, which outlines the device's substantial equivalence to a predicate device based on various performance and safety tests. However, it does not provide the specific "acceptance criteria" (e.g., minimum sensitivity, specificity, or accuracy thresholds) or the detailed methodology and results of a single study with the requested metrics.

    Instead, the document lists several non-clinical data submitted, which include performance and safety tests in accordance with ISO standards and other bench tests. The conclusion states that "Non-clinical verification and validation assessment/testing demonstrated that AirFit F30i NM and Arcadia mask systems met all intended performance requirements." and "Verification confirmed that the new device met the predetermined acceptance criteria and the performance is substantially equivalent to the previously cleared predicate AirFit F30i mask system (K183512)."

    Therefore, I can extract the types of tests performed and the comparison to the predicate device, but I cannot fill in the table or answer all sub-questions as the specific numerical acceptance criteria and a single "study" proving it with the requested detail are not present.

    Here's what can be extracted based on the provided text, with an explanation for missing information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are generally qualitative (e.g., "met all intended performance requirements") and tied to ISO standards or established performance of the predicate device. Specific numerical thresholds for acceptance are not explicitly listed in the 510(k) summary, except for some comparative parameters.

    Acceptance Criteria (General)Reported Device Performance (as compared to predicate)
    CO2 rebreathing (<20% for normal, <60% for single fault) (ISO 17510:2015 Annex F)Predicate (AirFit F30i): Normal Condition: 8.1% (4 cm H2O), 5.8% (5 cm H2O), 1.9% (10 cm H2O). Single Fault: 32.6% (Fault 1), 45.3% (Fault 2). AirFit F30i Mask System (Modified): Normal Condition: 7.7%, 5.2%, 1.5%. Single Fault: 42.5% (Fault 1), 55.1% (Fault 2). AirFit F30i NM Mask System (Modified - not listed, assumed similar to AirFit F30i Mask System for these parameters unless specified otherwise): Normal Condition: 7.7%, 5.2%, 1.5%. Single Fault: 42.5% (Fault 1), 55.1% (Fault 2). Arcadia Mask System (New): Normal Condition: Arcadia Mask 9.9%, 8.5%, 6.3%; Arcadia SLM 9.7%, 8.4%, 6.2%. Single Fault: Arcadia Mask 42.8% (Fault 1), 54.8% (Fault 2); Arcadia SLM 41.9% (Fault 1), 54.3% (Fault 2).
    Exhaust flow (ISO 17510:2015 Annex B)Predicate (AirFit F30i): 4 L/min @ 4 cm H2O, 31 L/min @ 9 cm H2O, 41 L/min @ 15 cm H2O, 49 L/min @ 20 cm H2O, 55 L/min @ 25 cm H2O. AirFit F30i Mask System (Modified): (Not explicitly listed, assumed similar to predicate or shown as equivalent). AirFit F30i NM Mask System (Modified): 22 L/min @ 4 cm H2O, 38 L/min @ 11 cm H2O, 48 L/min @ 17 cm H2O, 59 L/min @ 24 cm H2O, 67 L/min @ 30 cm H2O. Arcadia Mask System (New): 22 L/min @ 4 cm H2O, 39 L/min @ 11 cm H2O, 49 L/min @ 17 cm H2O, 60 L/min @ 24 cm H2O, 69 L/min @ 30 cm H2O.
    Resistance to flow (Pressure drop across mask in cmH₂O) (ISO 17510:2015 Annex C)Predicate (AirFit F30i): 0.2 @ 50 L/min, 1.0 @ 100 L/min. AirFit F30i Mask System (Modified): 0.2 @ 50 L/min, 1.0 @ 100 L/min. AirFit F30i NM Mask System (Modified): (Not explicitly listed, assumed similar to AirFit F30i Mask System). Arcadia Mask System (New): 0.3 @ 50 L/min, 1.2 @ 100 L/min.
    Anti-Asphyxia valve operating pressures (Open/Closed-to-atmosphere pressures <= 4 cm H2O) (ISO 17510:2015 Annex D)Predicate (AirFit F30i): <= 4 cm H2O. AirFit F30i Mask System (Modified): <= 4 cm H2O. AirFit F30i NM Mask System (Modified): < 4 cm H2O. Arcadia Mask System (New): (Not explicitly listed, stated as Equivalent to predicate).
    Breathing resistance (Inspiratory/Expiratory) (ISO 17510:2015 Annex E)Predicate (AirFit F30i): Inspiratory 0.2, Expiratory 0.3. AirFit F30i Mask System (Modified): Inspiratory 0.2, Expiratory 0.4. AirFit F30i NM Mask System (Modified): (Not explicitly listed, assumed similar to AirFit F30i Mask System). Arcadia Mask System (New): Inspiratory 0.2, Expiratory (Not explicitly listed).
    Vibration and noise (Sound power/pressure level) (ISO 17510:2015 Annex G)Predicate (AirFit F30i): Sound power level: 25 dBA, Sound pressure level: 18 dBA. AirFit F30i Mask System (Modified): Sound power level: 25 dBA, Sound pressure level: 18 dBA. AirFit F30i NM Mask System (Modified): Sound power level: 25 dBA, Sound pressure level: 18 dBA. Arcadia Mask System (New): Multi-hole vent, QuietAir vent, Sound power level: 22 dBA, Sound pressure level: 15 dBA.
    Mechanical IntegrityDemonstrated after home cleaning, transportation and storage, operation environment, free fall and sit test, reprocessing. (Passed, details not provided).
    BiocompatibilityEvaluated as per ISO 18562-1, ISO 10993-1 and applicable regulatory guidance. (Passed, details not provided).
    Reprocessing claimsValidated in accordance with ISO 17664-2, ST98 and AAMI TIR12, including cleaning efficacy, disinfection efficacy, residual toxicity, and mechanical integrity. (Passed, details not provided).
    Magnetic interferenceRisk assessment activities, including tests of magnetic field strength (<400mT on surface, <0.5mT at 50mm distance for devices with magnets), were conducted. (Passed, details not provided).

    Detailed numerical acceptance criteria for each test (e.g., "CO2 rebreathing must be less than X%") are not explicitly provided, but the document confirms that the devices "met all intended performance requirements" and "predetermined acceptance criteria." The performance characteristics are compared to the predicate device, often indicating "Equivalent" or "Identical."

    2. Sample size used for the test set and the data provenance

    • Sample Size: Not specified for any of the tests. The document refers to "non-clinical verification and validation assessment/testing."
    • Data Provenance: Not specified. These appear to be laboratory-based bench tests or in-house engineering tests. There is no indication of country of origin for data or if it's retrospective/prospective.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • This information is not applicable as the tests described are non-clinical, bench-top performance and safety evaluations, not typically requiring expert-driven ground truth establishment in the way clinical studies with diagnostic devices might.

    4. Adjudication method for the test set

    • This information is not applicable for the non-clinical, bench-top tests described.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • This information is not applicable. The device is a CPAP mask system, not an AI-assisted diagnostic or interpretive tool. Therefore, MRMC studies involving human readers and AI are not relevant.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • This information is not applicable. The device is a physical medical device (CPAP mask system), not a software algorithm or AI.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    • For the non-clinical tests described, the "ground truth" is typically defined by established engineering standards (e.g., ISO 17510:2015 parameters, pressure measurements, flow rates, CO2 concentration readings) and reference methods. For biocompatibility and reprocessing, it's based on validated test methods and safety thresholds defined by relevant ISO and AAMI standards.

    8. The sample size for the training set

    • This information is not applicable. The device is a physical medical device; there is no indication of a "training set" in the context of an algorithm or AI.

    9. How the ground truth for the training set was established

    • This information is not applicable for the same reason as point 8.
    Ask a Question

    Ask a specific question about this device

    K Number
    K230476
    Device Name
    Oran Park Mask
    Date Cleared
    2023-10-19

    (239 days)

    Product Code
    Regulation Number
    868.5905
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Oran Park mask is intended for use in the home or hospital/institutional environment on patients weighing more than 661b (30kg), who have been prescribed non-invasive CPAP or bi-level positive airway pressure (PAP) therapy.

    Only the Sleep Lab Mask (SLM) variant is intended and validated for multi-patient reuse and must be reprocessed if reused between patients.

    Device Description

    The Oran Park Mask is an accessory to deliver air flow and positive air pressure generated by positive airway pressure (PAP) devices such as CPAP or bi-level flow generator systems to the patient's airway, for the treatment of Obstructive Sleep Apnea (OSA) or ventilator support (non-life support). It delivers the treatment pressure from the source device to the patient's upper airway by providing an air seal between the PAP device and under the patient's nose and mouth.

    There are 2 variants to the Oran Park Mask:

    • . Oran Park Mask (Home Use) Intended for single patient re-use (SPMU) for home use. It is configured with a diffused venting port located on the elbow, known as the QuietAir elbow.
    • . Oran Park SLM (Sleep Lab Mask)

    Intended for multi-patient re-use (MPMU) and must be reprocessed if reused between patients. It is configured with a non-diffused venting port located on the elbow, known as the Multihole elbow.

    The Oran Park mask comprises of 4 sub-assemblies: headgear, frame, cushion and elbow. The venting ports and anti-asphyxia valve are incorporated into the elbow assembly. There are four magnets incorporated in the Oran Park mask – two magnets in the frame assembly and 2 magnets in the lower headgear clips – with a magnetic field strength up to 400 mT. The mask help facilitate attaching and detaching the headgear to the mask frame when regularly fitting the mask for use. The cushion and headgear are available in various sizes to fit a wide patient population. Soft wraps, which are attached to the Oran Park mask frame, are available as an optional accessory for patient's comfort.

    The Oran Park mask is a prescription device and is supplied non-sterile.

    AI/ML Overview

    The Oran Park Mask is a medical device accessory used to deliver airflow and positive air pressure from PAP devices for the treatment of Obstructive Sleep Apnea or ventilator support. The device underwent non-clinical testing to demonstrate its performance and safety, aiming to prove substantial equivalence to the predicate device, AirFit F20 (K153563).

    Here's an analysis of the acceptance criteria and the study that proves the device meets them:

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document presents a comparison table between the predicate device (AirFit F20, K153563) and the subject device (Oran Park Mask System) for various design parameters and features. The "Comments" column often indicates the acceptance criteria for the subject device by stating "Equivalent," "Identical," or referencing compliance with specific ISO standards.

    Acceptance Criteria / Design ParameterPredicate Device Performance (AirFit F20)Reported Device Performance (Oran Park Mask)Evaluation / Comment
    Indications for UseNon-invasive CPAP or bi-level PAP therapy for patients > 66lb (30kg). Single-patient reuse home, multi-patient reuse hospital/institutional.Non-invasive CPAP or bi-level PAP therapy for patients > 66lb (30kg). Home use: single-patient reuse. SLM variant: multi-patient reuse.Equivalent
    FDA Product CodeBZDBZDIdentical
    ReprocessingSingle patient re-use or multi-patient re-useSingle patient re-use (Oran Park Mask) or multi-patient re-use (Oran Park SLM)Identical
    Physical Dead Space (mL)Small: 199mL, Medium: 219mL, Large: 240mLSmall: 101.1mL, Medium: 107.6mL, Large: 107.0mLRecord-only parameter (implies this value is reported, not directly compared for equivalence acceptance, but still meets a performance standard if it's within expected range for masks)
    Leakage Flow (L/min) @ Specified Pressure (cmH2O)3cmH2O: 19, 4cmH2O: 22, 13cmH2O: 42, 22cmH2O: 57, 31cmH2O: 70, 40cmH2O: 82(No N/A for 3cmH2O), 4cmH2O: 20, 13cmH2O: 38, 22cmH2O: 51, 31cmH2O: 62, 40cmH2O: 72Equivalent (values are generally similar, within reasonable physiological range, and deemed acceptable)
    Use LifeAirFit F20 (single patient, multi-use): Visual inspection. AirFit F20 (multi patient, multi-use): 30 validated reprocessing cycles.Oran Park mask: Visual inspection. Oran Park SLM: 30 validated reprocessing cycles.Identical
    Operating and Storage TemperatureOperating: 5°C to 40°C, Storage: -20°C to +60°COperating: 5°C to 40°C, Storage: -20°C to +60°CIdentical
    Sound Power Level & PressureTested and declared in accordance with ISO4871 and ISO3744Tested and declared in accordance with ISO4871 and ISO3744Equivalent
    Cushion Assembly DesignSeals above nose and around mouthSeals under nose and around mouthEquivalent (due to prior clearance of 'under the nose' design)
    Elbow Assembly DesignBall joint, 360-degree rotationShort tube and swivel cuffEquivalent (in terms of decoupling and freedom of movement)
    Vent DesignMulti-hole Vent array in elbow assemblyTwo design variants: Multi-hole Vent, QuietAir VentEquivalent (both verified to satisfy ISO 17510:2015 mask pressure flow and CO2 rebreathing performance)
    AAV DesignTwo Anti-Asphyxia Valves (AAV)Single Anti-Asphyxia Valve (AAV)Equivalent (function is same, verification testing conducted)
    Patient Connection PortISO 5356-1 (22mm)ISO 5356-1 (22mm)Identical
    Flow Generator Setting on ResMed Flow GeneratorsFull Face MaskPillowsDifferent (but intended to achieve equivalent therapy at patient's airways via appropriate pressure compensation)
    Pressure Range3-40cmH2O4-40cmH2OSubset of predicate device (acceptable)
    Mask Exhaust Flow (Nominal, ISO 17510:2015 Annex B)(Values provided at various pressures)(Values provided at various pressures)Equivalent (implies the reported values are within an acceptable range compared to the predicate/standard)
    Resistance to Flow (Pressure drop across mask, ISO 17510:2015 Annex C)50L/min: 0.2cmH2O, 100L/min: 0.9cmH2O50L/min: 0.3cmH2O, 100L/min: 1.6cmH2OThe pressure drop values have been reported in accordance with ISO17510:2015. (Implies compliance with standard limits, thus acceptable).
    CO2 Re-breathing Performance (<20%, ISO 17510:2015 Annex F)Complies with ISO 17510:2015 CO2 requirements (<20%)Complies with ISO 17510:2015 CO2 requirements (<20%)Equivalent
    CO2 Re-breathing Single Fault Use (<60%, ISO 17510:2015 Annex F)Complies with ISO 17510:2015 CO2 requirements (<60%)Complies with ISO 17510:2015 CO2 requirements (<60%)Equivalent
    Breathing Resistance (single fault) (Inspiratory & Expiratory, <10cmH2O, ISO 17510:2015 Annex E)<10cmH2O (Inspiratory), <10cmH2O (Expiratory)<10cmH2O (Inspiratory), <10cmH2O (Expiratory)Equivalent
    AAV Operating Pressures (Deactivation & Activation, <4.0cmH2O, ISO 17510:2015 Annex D)<4.0 cmH2O (Deactivation), <4.0 cmH2O (Activation)<4.0 cmH2O (Deactivation), <4.0 cmH2O (Activation)Equivalent

    2. Sample Size Used for the Test Set and Data Provenance:

    The document describes non-clinical verification and validation testing. This type of testing typically involves bench tests on manufactured devices rather than studies on human subjects. Therefore, the concept of "test set" in the context of patient data, sample size of patients, and data provenance (country of origin, retrospective/prospective) is not applicable here. The tests are performed on the device prototypes or production samples in a laboratory setting. No information is provided regarding the number of units tested for each non-clinical test.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:

    This information is also not applicable as the study described is non-clinical, involving engineering and performance testing against established standards and predicate device performance, not clinical interpretation requiring expert ground truth establishment.

    4. Adjudication Method (2+1, 3+1, none) for the Test Set:

    This information is not applicable for the same reasons as points 2 and 3. Non-clinical bench testing does not involve adjudication methods used in clinical studies.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    This is not applicable. The device, an Oran Park Mask, is a physical patient interface for respiratory therapy. It is not an AI-powered diagnostic or assistive tool, so an MRMC study comparing human reader performance with and without AI assistance would not be relevant.

    6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done:

    This is not applicable. The device is a physical mask, not an algorithm.

    7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.):

    For the non-clinical tests, the "ground truth" or reference for acceptance was primarily:

    • International Standards: Specifically ISO 17510:2015 (Medical devices – Sleep apnoea breathing therapy – Masks and application accessories), ISO 10993 series (Biocompatibility), ISO 18562 series (Biocompatibility of breathing gas pathways), ISO 5356-1 (Conical connectors), etc.
    • Performance of the Predicate Device: The AirFit F20 (K153563) served as a direct comparison for various parameters to establish substantial equivalence.
    • Predetermined Acceptance Criteria: These are likely internal specifications derived from the standards and predicate device performance, ensuring safety and effectiveness.

    8. The Sample Size for the Training Set:

    This is not applicable as there is no "training set" in the context of non-clinical device testing for a physical mask. Device design and validation follow engineering and regulatory processes, not machine learning training.

    9. How the Ground Truth for the Training Set Was Established:

    This is not applicable for the reasons stated in point 8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K223747
    Date Cleared
    2023-07-06

    (204 days)

    Product Code
    Regulation Number
    868.5905
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Whitsundays Mask System has two product variants:
    • Whitsundays mask
    · Whitsundays SLM (Sleep Lab Mask)
    Both masks are intended for patients weighing more than 66 lb (30 kg), who have been prescribed non-invasive CPAP or bi-level positive airway pressure (PAP) therapy. The Whitsundays mask is intended for single-patient reuse in the home environment and the Whitsundays SLM is intended for multi-patient reuse in the hospital/institutional environment. The Sleep Lab Mask (SLM) is the only variant that is validated and intended for multi-patient reprocessing and must be reprocessed if reused between patients.

    Device Description

    The Whitsundays Mask System is an accessory to deliver airflow and positive air pressure generated by positive airway pressure (PAP) devices such as CPAP or bi-level flow generator systems to the patient's airway, for the treatment of Obstructive Sleep Apnea (OSA) or ventilatory support (non-life support). It delivers the treatment pressure from the source to the patient's upper airway by providing an air seal between the PAP device and the bottom of the patient's nose.
    The Whitsundays mask system has two product variants:

    • Whitsundays mask This is the home use variant that is intended for single patient re-use.
    • . Whitsundays SLM (Sleep Lab Mask) This is the SLM variant that is intended for multi-patient re-use and must be reprocessed if reused between patients.
      The Whitsundays Mask System is made up of 4 main component assemblies: nasal cushion, conduit frame, elbow, and headgear. The nasal cushion and conduit frame are available in various sizes to allow for adequate mask fit in the intended patient population.
      The Whitsundays Mask System is a prescription device supplied non- sterile.
    AI/ML Overview

    The provided text describes the ResMed Whitsundays Mask System and its substantial equivalence to a predicate device, the Scone mask (K180497). The document focuses on non-clinical data and acceptance criteria based on recognized standards.

    Here's the breakdown of the acceptance criteria and the study information:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria / Design ParameterPredicate Device Performance (Scone mask)Reported Device Performance (Whitsundays Mask System)Acceptance Criteria Comment
    Mask Exhaust Flow (Nominal) (ISO 17510:2015 Annex B)
    - Pressure 4 cm H2O20 L/min20 L/minIdentical
    - Pressure 9 cm H2O31 L/min31 L/minIdentical
    - Pressure 15 cm H2O41 L/min41 L/minIdentical
    - Pressure 20 cm H2O49 L/min49 L/minIdentical
    - Pressure 25 cm H2O55 L/min55 L/minIdentical
    CO2 Re-breathing Performance (ISO 17510:2015 Annex F)Complies (<20%)Complies (<20%)Identical (Acceptance criterion is <20% CO2 re-breathing as per ISO 17510:2015)
    Physical Dead Space (mL)
    - Frame SML, Cushion S109109Equivalent (This is a record-only parameter, meaning values are reported rather than needing to meet a specific pass/fail threshold against the predicate, as long as they are comparable)
    - Frame SML, Cushion SW105105Equivalent
    - Frame SML, Cushion M113113Equivalent
    - Frame STD, Cushion S116116Equivalent
    - Frame STD, Cushion SW112112Equivalent
    - Frame STD, Cushion M120120Equivalent
    - Frame SML, Cushion L119119Equivalent
    - Frame STD, Cushion L127127Equivalent
    Resistance to Flow (Pressure drop across mask in cmH2O) (ISO 17510:2015 Annex C)
    - @50 L/min0.50.4Resistance to flow values are reported in the instructions for use in accordance with ISO 17510:2015. The subject device has slightly lower resistance, indicating equivalent or improved performance.
    - @100 L/min2.31.6Resistance to flow values are reported in the instructions for use in accordance with ISO 17510:2015. The subject device has significantly lower resistance, indicating equivalent or improved performance.
    Sound
    - Sound power level21 dBA24 dBAEquivalent. While the new device has a slightly higher sound power level (3 dBA increase), this is generally considered a minor difference in acoustic metrics and unlikely to raise new safety or effectiveness concerns, fitting within an "equivalent" assessment for regulatory purposes for this type of device.
    - Sound pressure level14 dBA17 dBAEquivalent. Similar to sound power, a 3 dBA increase in sound pressure is often considered acoustically equivalent or minor in regulatory context for patient comfort if within acceptable ranges, not raising new safety or effectiveness concerns.
    BiocompatibilityMaterials used in predicateNew materials for nasal cushion and conduit frame sleeveEquivalent. All new materials have been included in previously cleared submissions or underwent biological evaluation as per ISO 10993-1 and ISO 18562-1, meeting the acceptance criteria for biocompatibility.
    Reprocessing Claims ValidationSingle/multi-patient re-use (Scone SLM: 30 cycles)Single/multi-patient re-use (Whitsundays SLM: 30 cycles)Identical. Validation performed in accordance with ISO 17664-1 and ISO 17664-2, including cleaning efficacy, disinfection efficacy, residual toxicity, and mechanical integrity testing, ensuring the reprocessing claims are met for the specified use life.
    Mechanical IntegrityNot explicitly detailedMet all intended performance requirementsNew device completed non-clinical verification and validation testing, including mechanical integrity before and after environmental tests (home cleaning, transportation, storage, operation, free fall, sit test, cleaning, and reprocessing). The acceptance criteria are that the device maintains its mechanical integrity under these conditions.

    2. Sample size used for the test set and the data provenance

    The document refers to "non-clinical verification and validation testing" and "bench tests" for performance characteristics. The specific sample sizes for these tests are not provided in the summary.

    The data provenance is from bench testing conducted by ResMed Pty Ltd. This is a form of prospective testing, as it involves newly manufactured devices undergoing controlled experiments. The country of origin for the company is Australia.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not provided in the document. The studies are primarily engineering and performance tests against recognized standards (e.g., ISO, rather than clinical studies requiring expert ground truth for interpretation like imaging).

    4. Adjudication method for the test set

    Not applicable. The evaluations are based on quantifiable measurements against established standards (e.g., flow rates, pressure drops, CO2 levels) rather than subjective assessments requiring adjudication.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable. The device is a medical mask and not an AI-powered diagnostic or assistive tool for human readers.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This is not applicable. The device is a physical medical mask, not an algorithm.

    7. The type of ground truth used

    The "ground truth" for the non-clinical tests is established by international standards such as ISO 17510:2015, ISO 18562, ISO 10993, and ISO 17664. These standards define the acceptable performance limits and methodologies for testing. For some parameters like physical dead space, the "ground truth" is the measured value of the predicate device, against which the new device's measurements are compared for equivalence.

    8. The sample size for the training set

    This is not applicable. The device is a physical medical mask, not a machine learning model that requires a training set.

    9. How the ground truth for the training set was established

    This is not applicable for the same reason as above.

    Ask a Question

    Ask a specific question about this device

    K Number
    K203126
    Device Name
    S10 Kirra
    Manufacturer
    Date Cleared
    2020-12-18

    (60 days)

    Product Code
    Regulation Number
    868.5905
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The S10 Kirra is indicated to provide CPAP and Bi-level therapy for the treatment of obstructive sleep apnea (OSA) in patients (female patients with mild to moderate OSA when using AfH treatment mode) weighing more than 66 lb (30 kg). ASV and ASVAuto modes are also indicated for the treatment of central and/or mixed apneas, or periodic breathing. It is intended for home and hospital use.

    Device Description

    The S10 Kirra is a prescription only Positive Airway Pressure (PAP) ventilator device intended to treat individuals that are diagnosed with sleep apnea conditions. The S10 Kirra uses a micro-processor controlled blower, along with pressure and flow sensors, to achieve pressure, flow and time regulation of air delivery. It includes optional humidification, with air delivery to the patient via heated or non-heated breathing circuits. The device provides both therapeutic (e.g. tidal volume) and technical data (e.g. system fault), and a user interface allowing adjustment of device parameters. The device uses an external AC power supply, and allows the addition of low flow supplemental oxygen.

    AI/ML Overview

    The provided text describes the S10 Kirra, a non-continuous ventilator, and its substantial equivalence to predicate devices, but it does not contain the detailed information necessary to answer all parts of your request about acceptance criteria and a specific study proving the device meets them.

    The document focuses on demonstrating substantial equivalence to previously cleared predicate devices (S9 Greenhills, S9 Wanda, S9 Elouera), rather than detailing a new study with acceptance criteria for a novel device.

    Here's a breakdown of what can be extracted and what is missing:


    1. A table of acceptance criteria and the reported device performance

    The document states:
    "Verification confirmed the S10 Kirra met the predetermined acceptance criteria as defined in the relevant compliance standards and as defined in the system verification protocols."

    However, it does not provide a table listing specific acceptance criteria values and the reported performance for each criterion. It broadly mentions areas of testing:

    • Pressure performance
    • Breath events (flow limitations, snore, apneas)
    • Response to periodic breathing
    • Humidification

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    This information is not available in the provided text. The document refers to "verification bench testing" and "comparative predicate testing" but does not specify sample sizes for test sets or data provenance (country of origin, retrospective/prospective).


    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not available. The document focuses on bench testing and comparison to predicate devices, not human expert evaluations for ground truth.


    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not available. Adjudication methods are typically relevant for studies involving human interpretation or subjective assessments, which are not detailed here.


    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    The document explicitly states:
    "Clinical performance data is not required as the subject device uses established therapeutic technology and bench testing is sufficient to demonstrate substantial equivalence."

    Therefore, no MRMC comparative effectiveness study was done as the device relies on established technology, and its performance was evaluated through non-clinical bench testing.


    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    The entire non-clinical data section describes performance of the device itself (hardware and software), which can be considered a standalone performance assessment in a bench testing environment. The listed performance areas (pressure, breath events, humidification) are intrinsic to the device's function.


    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the non-clinical bench testing, the "ground truth" would be established by engineering specifications, compliance standards, and the performance characteristics of the predicate devices. The tests evaluate if the S10 Kirra performs according to these pre-defined, measurable engineering and physiological parameters. It is not based on expert consensus, pathology, or outcomes data in the way these terms are typically used for clinical evaluations.


    8. The sample size for the training set

    This information is not applicable/available. The S10 Kirra is a medical device (ventilator) with microprocessor control, not an AI/machine learning algorithm that requires a "training set" in the computational sense. The device's "training" involves design, engineering, and calibration to meet its specifications, rather than data-driven model training.


    9. How the ground truth for the training set was established

    This information is not applicable/available for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1